Cellular FXIII in Human Macrophage-Derived Foam Cells.
atherosclerotic plaque
cross-linking
enzyme-modified LDL
factor XIII
foam cells
macrophages
oxidized LDL
transglutaminase
vascular smooth muscle cells
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
02 Mar 2023
02 Mar 2023
Historique:
received:
30
01
2023
revised:
24
02
2023
accepted:
01
03
2023
entrez:
11
3
2023
pubmed:
12
3
2023
medline:
15
3
2023
Statut:
epublish
Résumé
Macrophages express the A subunit of coagulation factor XIII (FXIII-A), a transglutaminase which cross-links proteins through Nε-(γ-L-glutamyl)-L-lysyl iso-peptide bonds. Macrophages are major cellular constituents of the atherosclerotic plaque; they may stabilize the plaque by cross-linking structural proteins and they may become transformed into foam cells by accumulating oxidized LDL (oxLDL). The combination of oxLDL staining by Oil Red O and immunofluorescent staining for FXIII-A demonstrated that FXIII-A is retained during the transformation of cultured human macrophages into foam cells. ELISA and Western blotting techniques revealed that the transformation of macrophages into foam cells elevated the intracellular FXIII-A content. This phenomenon seems specific for macrophage-derived foam cells; the transformation of vascular smooth muscle cells into foam cells fails to induce a similar effect. FXIII-A containing macrophages are abundant in the atherosclerotic plaque and FXIII-A is also present in the extracellular compartment. The protein cross-linking activity of FXIII-A in the plaque was demonstrated using an antibody labeling the iso-peptide bonds. Cells showing combined staining for FXIII-A and oxLDL in tissue sections demonstrated that FXIII-A-containing macrophages within the atherosclerotic plaque are also transformed into foam cells. Such cells may contribute to the formation of lipid core and the plaque structurization.
Identifiants
pubmed: 36902231
pii: ijms24054802
doi: 10.3390/ijms24054802
pmc: PMC10002485
pii:
doi:
Substances chimiques
Factor XIII
9013-56-3
Lipoproteins, LDL
0
Peptides
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
J Exp Med. 1984 Jan 1;159(1):114-25
pubmed: 6141210
J Thromb Haemost. 2011 Jan;9(1):9-20
pubmed: 20880254
Thromb Res. 1985 Feb 1;37(3):401-10
pubmed: 2859670
Cell Immunol. 2004 Apr;228(2):81-90
pubmed: 15219459
Circulation. 2014 Apr 15;129(15):1551-9
pubmed: 24481950
Eur J Cell Biol. 1985 Jul;38(1):171-3
pubmed: 3896808
Thromb Haemost. 1988 Apr 8;59(2):231-5
pubmed: 2898817
Front Cardiovasc Med. 2022 Apr 13;9:845942
pubmed: 35498045
Cell Stem Cell. 2020 Jan 2;26(1):81-96.e4
pubmed: 31883835
J Immunol Methods. 2001 Dec 1;258(1-2):127-35
pubmed: 11684129
Int J Mol Sci. 2021 Jun 22;22(13):
pubmed: 34206377
J Clin Invest. 1985 Aug;76(2):528-34
pubmed: 2863285
Semin Thromb Hemost. 2016 Jun;42(4):422-8
pubmed: 27019464
Thromb Haemost. 2001 May;85(5):845-51
pubmed: 11372678
Int J Mol Sci. 2021 Mar 17;22(6):
pubmed: 33802692
Physiol Rev. 2011 Jul;91(3):931-72
pubmed: 21742792
Med Sci (Basel). 2018 Dec 11;6(4):
pubmed: 30545030
Circ Res. 1998 Aug 10;83(3):264-9
pubmed: 9710118
J Thromb Haemost. 2019 Jan;17(1):19-30
pubmed: 30489000
Semin Thromb Hemost. 2016 Jun;42(4):445-54
pubmed: 27056150
Int J Mol Sci. 2021 Jun 19;22(12):
pubmed: 34205443
Mediators Inflamm. 2013;2013:198193
pubmed: 24062612
Front Cardiovasc Med. 2022 Feb 14;9:777822
pubmed: 35237673
Cell Mol Life Sci. 2005 Sep;62(18):2132-9
pubmed: 16132226
Antioxidants (Basel). 2021 Mar 26;10(4):
pubmed: 33810295
Thromb Haemost. 2012 Dec;108(6):1172-9
pubmed: 23052999
Eur J Pharmacol. 2017 Dec 5;816:14-24
pubmed: 28989084
Thromb Haemost. 2010 Oct;104(4):709-17
pubmed: 20664907
Atherosclerosis. 2016 May;248:170-8
pubmed: 27038418
Circulation. 1995 Sep 1;92(5):1355-74
pubmed: 7648691
Cardiovasc Res. 2012 Jul 15;95(2):156-64
pubmed: 22406749
Blood. 2010 Apr 1;115(13):2674-81
pubmed: 20086247
Arterioscler Thromb Vasc Biol. 1999 Oct;19(10):2348-54
pubmed: 10521363